Literature DB >> 15982301

A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice.

Sven Hendrix1, Bori Handjiski, Eva M J Peters, Ralf Paus.   

Abstract

After chemical, biological, or physical damage, growing (i.e. anagen) hair follicles develop abnormalities that are collectively called hair follicle dystrophy. Comparatively lower follicular damage induces the "dystrophic anagen" response pathway (=prolonged, dystrophic anagen, followed by severely retarded follicular recovery). More severe follicular damage induces the dystrophic catagen pathway (=immediate anagen termination, followed by a dystrophic, abnormally shortened telogen and maximally fast follicular recovery). In order to recognize these distinct damage response strategies of the hair follicle in a clinical or histopathological context, we have used the well-established C57BL/6J mouse model of cyclophosphamide-induced alopecia to define pragmatic classification criteria for hair follicle dystrophy (e.g., structure and pigmentation of the hair shaft, location, and volume of ectopic melanin granules, distension of follicular canal, number of TdT-mediated dUTP nick end labeling positive keratinocytes in the hair bulb; neural cell-adhesion molecule immunoreactivity and alkaline phosphatase activity as markers for the level of damage to the follicular papilla). These classification criteria for hair follicle dystrophy are useful not only in chemotherapy-induced alopecia models, but also in the screening of drug-treated or mutant mice in a highly standardized, accurate, sensitive, reproducible, easily applicable, and quantifiable manner.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982301     DOI: 10.1111/j.0022-202X.2005.23787.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  27 in total

1.  A novel rat model for chemotherapy-induced alopecia.

Authors:  T C Wikramanayake; S Amini; J Simon; L M Mauro; G Elgart; L A Schachner; J J Jimenez
Journal:  Clin Exp Dermatol       Date:  2012-04       Impact factor: 3.470

2.  Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model.

Authors:  Ranjitha Katikaneni; Tulasi Ponnapakkam; Osamu Matsushita; Joshua Sakon; Robert Gensure
Journal:  Anticancer Drugs       Date:  2014-01       Impact factor: 2.248

3.  Gata6 promotes hair follicle progenitor cell renewal by genome maintenance during proliferation.

Authors:  Alex B Wang; Ying V Zhang; Tudorita Tumbar
Journal:  EMBO J       Date:  2016-12-01       Impact factor: 11.598

4.  Accelerated senescence in skin in a murine model of radiation-induced multi-organ injury.

Authors:  Elizabeth A McCart; Rajesh L Thangapazham; Eric D Lombardini; Steven R Mog; Ronald Allan M Panganiban; Kelley M Dickson; Rihab A Mansur; Vitaly Nagy; Sung-Yop Kim; Reed Selwyn; Michael R Landauer; Thomas N Darling; Regina M Day
Journal:  J Radiat Res       Date:  2017-09-01       Impact factor: 2.724

5.  Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia.

Authors:  Hisayoshi Imanishi; Daisuke Tsuruta; Chiharu Tateishi; Koji Sugawara; Ralf Paus; Tsutomu Tsuji; Masamitsu Ishii; Kazuo Ikeda; Hiroyuki Kunimoto; Koichi Nakajima; Jonathan C R Jones; Hiromi Kobayashi
Journal:  J Dermatol Sci       Date:  2010-02-16       Impact factor: 4.563

6.  Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner.

Authors:  Ranjitha Katikaneni; Tulasi Ponnapakkam; Andrew Seymour; Joshua Sakon; Robert Gensure
Journal:  Anticancer Drugs       Date:  2014-08       Impact factor: 2.248

7.  A new strategy to prevent chemotherapy and radiotherapy-induced alopecia using topically applied vasoconstrictor.

Authors:  Cheryl M Soref; William E Fahl
Journal:  Int J Cancer       Date:  2014-05-16       Impact factor: 7.396

8.  Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy.

Authors:  Eniko Bodó; Desmond J Tobin; York Kamenisch; Tamás Bíró; Mark Berneburg; Wolfgang Funk; Ralf Paus
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

9.  Inflammatory mediator TAK1 regulates hair follicle morphogenesis and anagen induction shown by using keratinocyte-specific TAK1-deficient mice.

Authors:  Koji Sayama; Kentaro Kajiya; Koji Sugawara; Shintaro Sato; Satoshi Hirakawa; Yuji Shirakata; Yasushi Hanakawa; Xiuju Dai; Yumiko Ishimatsu-Tsuji; Daniel Metzger; Pierre Chambon; Shizuo Akira; Ralf Paus; Jiro Kishimoto; Koji Hashimoto
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

10.  Selenoproteins are essential for proper keratinocyte function and skin development.

Authors:  Aniruddha Sengupta; Ulrike F Lichti; Bradley A Carlson; Andrew O Ryscavage; Vadim N Gladyshev; Stuart H Yuspa; Dolph L Hatfield
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.